TOP TEN perturbations for NM_000278 (Homo sapiens)

Organism: Homo sapiens
Gene: NM_000278
Selected probe(set): 206228_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of NM_000278 (206228_at) across 5339 perturbations tested by GENEVESTIGATOR:

collecting duct carcinoma study 1 / normal kidney tissue

Relative Expression (log2-ratio):-4.45914
Number of Samples:2 / 2
Experimental collecting duct carcinoma study 1
Tumor tissue samples from the kidney of patients with collecting duct carcinoma (CDC).
Control normal kidney tissue
Normal fetal kidney tissue samples.

ovarian tumor study 26 (serous carcinoma; metastase; peritoneum) / ovarian tumor study 26 (serous carcinoma; borderline; primary)

Relative Expression (log2-ratio):-3.3468742
Number of Samples:15 / 30
Experimental ovarian tumor study 26 (serous carcinoma; metastase; peritoneum)
Metastatic tumor tissue sample obtained from the peritoneum of female patients with primary serous cystadenocarcinoma of the ovary.
Control ovarian tumor study 26 (serous carcinoma; borderline; primary)
Ovarian tissue samples from female patients with primary serous cystadenoma with low malignant potential (borderline).

ovarian tumor study 27 (papillary serous cystadenocarcinoma; metastase) / ovarian tumor study 27 (papillary serous cystadenocarcinoma; bmp; primary)

Relative Expression (log2-ratio):-3.2403736
Number of Samples:53 / 18
Experimental ovarian tumor study 27 (papillary serous cystadenocarcinoma; metastase)
Metastatic tumor tissue samples obtained from different anatomical sites (colon, omentum, peritoneum and unstated sites) of female patients with primary papillary serous cystadenocarcinoma of the ovary.
Control ovarian tumor study 27 (papillary serous cystadenocarcinoma; bmp; primary)
Primary tumor tissue samples obtained from the ovary of female patients with papillary serous cystadenocarcinoma with borderline malignant potential (bmp).

collecting duct carcinoma study 1 / normal kidney tissue

Relative Expression (log2-ratio):-3.2039366
Number of Samples:2 / 3
Experimental collecting duct carcinoma study 1
Tumor tissue samples from the kidney of patients with collecting duct carcinoma (CDC).
Control normal kidney tissue
Normal adult kidney tissue samples.

oxyphilic adenoma study 1 / normal kidney tissue

Relative Expression (log2-ratio):-2.5578814
Number of Samples:4 / 2
Experimental oxyphilic adenoma study 1
Tumor tissue samples from the kidney of patients with oxyphilic adenoma (renal oncocytoma).
Control normal kidney tissue
Normal fetal kidney tissue samples.

ovarian tumor study 27 (papillary serous cystadenocarcinoma; primary) / ovarian tumor study 27 (papillary serous cystadenocarcinoma; bmp; primary)

Relative Expression (log2-ratio):-2.306181
Number of Samples:153 / 18
Experimental ovarian tumor study 27 (papillary serous cystadenocarcinoma; primary)
Primary tumor tissue samples obtained from the ovary of female patients with papillary serous cystadenocarcinoma.
Control ovarian tumor study 27 (papillary serous cystadenocarcinoma; bmp; primary)
Primary tumor tissue samples obtained from the ovary of female patients with papillary serous cystadenocarcinoma with borderline malignant potential (bmp).

renal cell carcinoma study 6 (chromophobe type) / normal kidney tissue

Relative Expression (log2-ratio):-2.2529964
Number of Samples:4 / 2
Experimental renal cell carcinoma study 6 (chromophobe type)
Tumor tissue samples from the kidney of patients with chromophobe renal cell carcinoma (cRCC).
Control normal kidney tissue
Normal fetal kidney tissue samples.

ovarian tumor study 11 (low grade) / normal ovarian surface epithelial cell sample

Relative Expression (log2-ratio):2.224638
Number of Samples:11 / 6
Experimental ovarian tumor study 11 (low grade)
Human microdissected tumor cells from the ovary of patients with low grade serous carcinoma.
Control normal ovarian surface epithelial cell sample
Human microdissected ovarian surface epithelial cell sample from the ovary of healthy individuals.

endometriosis study 2 / normal endometrium tissue

Relative Expression (log2-ratio):-2.2111368
Number of Samples:10 / 10
Experimental endometriosis study 2
Endometrium tissue from patients with endometriosis.
Control normal endometrium tissue
Normal endometrium tissue.

ovarian tumor study 26 (serous carcinoma; malignant; primary) / ovarian tumor study 26 (serous carcinoma; borderline; primary)

Relative Expression (log2-ratio):-2.1322336
Number of Samples:44 / 30
Experimental ovarian tumor study 26 (serous carcinoma; malignant; primary)
Ovarian tissue samples from female patients with primary serous cystadenocarcinoma.
Control ovarian tumor study 26 (serous carcinoma; borderline; primary)
Ovarian tissue samples from female patients with primary serous cystadenoma with low malignant potential (borderline).